104 related articles for article (PubMed ID: 28990842)
1. MicroRNA-655-3p regulates Echinacea purpurea mediated activation of ABCG2.
Awortwe C; Kaehler M; Rosenkranz B; Cascorbi I; Bruckmueller H
Xenobiotica; 2018 Oct; 48(10):1050-1058. PubMed ID: 28990842
[TBL] [Abstract][Full Text] [Related]
2. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
Ripperger A; Benndorf RA
Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression.
Turrini E; Haenisch S; Laechelt S; Diewock T; Bruhn O; Cascorbi I
Pharmacogenet Genomics; 2012 Mar; 22(3):198-205. PubMed ID: 22241070
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Phytocompounds of
Awortwe C; Bruckmueller H; Kaehler M; Cascorbi I
Mol Pharm; 2021 Apr; 18(4):1622-1633. PubMed ID: 33730506
[TBL] [Abstract][Full Text] [Related]
5. Clinically Relevant Multidrug Transporters Are Regulated by microRNAs along the Human Intestine.
Bruckmueller H; Martin P; Kähler M; Haenisch S; Ostrowski M; Drozdzik M; Siegmund W; Cascorbi I; Oswald S
Mol Pharm; 2017 Jul; 14(7):2245-2253. PubMed ID: 28510455
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E
Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687
[TBL] [Abstract][Full Text] [Related]
7. Clinically relevant interactions of anti-apoptotic Bcl-2 protein inhibitors with ABC transporters.
Ruzickova E; Janska R; Dolezel P; Mlejnek P
Pharmazie; 2017 Dec; 72(12):751-758. PubMed ID: 29441961
[TBL] [Abstract][Full Text] [Related]
8. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
To KK; Leung WW; Ng SS
Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
[TBL] [Abstract][Full Text] [Related]
9. Silencing of ABCG2 by MicroRNA-3163 Inhibits Multidrug Resistance in Retinoblastoma Cancer Stem Cells.
Jia M; Wei Z; Liu P; Zhao X
J Korean Med Sci; 2016 Jun; 31(6):836-42. PubMed ID: 27247490
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.
Pan YZ; Morris ME; Yu AM
Mol Pharmacol; 2009 Jun; 75(6):1374-9. PubMed ID: 19270061
[TBL] [Abstract][Full Text] [Related]
11. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
[TBL] [Abstract][Full Text] [Related]
12. Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells.
Kania KD; Wijesuriya HC; Hladky SB; Barrand MA
Brain Res; 2011 Oct; 1418():1-11. PubMed ID: 21920506
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells.
Rodrigues AC; Neri EA; Veríssimo-Filho S; Rebouças NA; Hirata RD; Yu AM
Eur J Pharm Sci; 2016 Oct; 93():431-6. PubMed ID: 27575876
[TBL] [Abstract][Full Text] [Related]
14. Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.
To KK; Zhan Z; Litman T; Bates SE
Mol Cell Biol; 2008 Sep; 28(17):5147-61. PubMed ID: 18573883
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
16. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
17. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
18. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
19. Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2.
To KK; Robey RW; Knutsen T; Zhan Z; Ried T; Bates SE
Mol Cancer Ther; 2009 Oct; 8(10):2959-68. PubMed ID: 19825807
[TBL] [Abstract][Full Text] [Related]
20. Lipid regulation of the ABCB1 and ABCG2 multidrug transporters.
Hegedüs C; Telbisz Á; Hegedűs T; Sarkadi B; Özvegy-Laczka C
Adv Cancer Res; 2015; 125():97-137. PubMed ID: 25640268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
